Somerset Indus Capital Partners 
Dealstreet

ELP advises Somerset Indus Capital Partners in its investment in Natural Biogenex

The investment amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Natural Biogenex Private Limited, a company manufacturing steroidal APIs.

This marks the fund’s sixth overall investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this investment.

The transaction team consisted of Vinay Butani (Partner), Rudraksh Bhatt (Senior Associate) and Faiz Thakur (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Judicial independence in politically sensitive cases a mixed bag: Abhishek Manu Singhvi

Plea in Supreme Court seeks fresh probe into US govt indictment against Gautam Adani

Karnataka withdraws compulsory arbitration clause from State tenders, contracts

Bombay High Court acquits Assistant Public Prosecutor, law clerk in 22-year-old bribery case

Committee being set up to examine Deepfake issue: Centre tells Delhi High Court

SCROLL FOR NEXT